methionine aminopeptidase (maP) (e.C. 3.4.11.18) is a metallopeptidase that cleaves the N-terminal methionine (met) residue from some proteins. maP is essential for growth of several bacterial pathogens, making it a target for antibacterial drug discovery. maP enzymes are also present in eukaryotic cells, and one is a target for antiangiogenic cancer therapy. to screen large compound libraries for maP inhibitors as the starting point for drug discovery, a high-throughput-compatible assay is valuable. here the authors describe a novel assay, which detects the met product of maP-catalyzed peptide cleavage by coupling it to adenosine triphosphate (atP)-dependent production of S-adenosyl-l-methionine (Sam) and inorganic phosphate (P i ) by Sam synthetase (metK) combined with inorganic pyrophosphatase. the three P i ions produced for each met consumed are detected using malachite Green/molybdate reagent. this assay can use any unmodified peptide maP substrate with an N-terminal met. the assay was used to measure kinetic constants for Escherichia coli maP using mn 2+ as the activator and the peptide met-Gly-met-met as the substrate, as well as to measure the potency of a maP inhibitor. a mn 2+ buffer is described that can be used to prevent free mn 2+ depletion by chelating compounds from interfering in screens for maP inhibitors. (Journal of Biomolecular Screening 2011;16:494-505) 
R
emoval of the N-termiNal iNitiator methioNiNe (met) residue by the metalloenzyme methionine aminopeptidase (maP) is an important step in the co-or posttranslational maturation, targeting, and ultimately degradation of many proteins. [1] [2] [3] [4] [5] this enzyme has been shown to be essential in bacteria and yeast. [6] [7] [8] inhibition of maP leads to cell cycle arrest in mammalian cells. 9 maP is the target of the well-studied antiangiogenesis compound fumagillin and later analogues. 10 maP inhibitors have the potential to be therapies for cancer, 11 arthritis, 12 malaria, 13 microsporidiosis, 14 and bacterial infections. [15] [16] [17] in the search for maP inhibitors as the starting points for drug discovery, a high-throughput assay for maP enzyme activity (i.e., one compatible with the use of multiwell assay plates and automation) is a valuable asset. Such an assay is useful for screening chemical compound and natural product extract collections, enabling rapid and convenient quantitation of inhibitor potency, and determining the kinetic mechanism of inhibition.
Several high-throughput-compatible assays for maP have been described. Yang et al. 18 introduced a coupled spectrophotometric assay in which the met released by maP from an oligopeptide substrate was used by l-amino acid oxidase as a substrate in the generation of hydrogen peroxide (h 2 o 2 ). the h 2 o 2 was then used by horseradish peroxidase to convert o-dianisidine to a colored product or to convert amplex red to fluorescent resorufin. Zhou et al. 19 reported two absorbance-based maP assays. in the first assay, a thioester substrate was converted by maP into a product containing a free thiol group that was detected with ellman's reagent. in the second assay, maP was combined with prolyl aminopeptidase to release the colored product p-nitroanilide from the substrate met-Pro-p-nitroanilide. reducing the maP substrate to the bare minimum, mitra et al. 20 reported an absorbance-based assay using l-met-p-nitroanilide as the chromogenic substrate, and li et al. 21 described a fluorescence-based assay using l-met-aminomethylcoumarin as the fluorogenic substrate.
in this article, we describe a novel maP assay in which the product met and adenosine triphosphate (atP) are the substrates for S-adenosyl-l-methionine (Sam) synthetase (e.C. 2.5.1.6), also known as methionine adenosyltransferase, producing Sam, inorganic pyrophosphate (PP i ), and inorganic phosphate (P i ). 22 inorganic pyrophosphatase (PP i ase) (e.C.
3.6.1.1) converts the PP i to 2 P i , 23 and thus three equivalents of P i are produced for each equivalent of met. this new assay, like that of Yang et al., 18 has the advantage of being able to use any maP substrate, including readily obtainable short oligopeptides. further flexibility comes from the ability to use any suitable means of P i detection. We illustrate P i detection in the new maP assay using malachite Green/molybdate reagent 24 with an endpoint absorbance measurement. the malachite Green/ molybdate reagent offers low cost, simplicity of preparation and use, long-term storage stability, high sensitivity, and a history of robust performance in our hands for high-throughput screening (htS). maP activity requires a divalent transition metal such as mn . in this article, we use mn 2+ as the activator. the maP assay has been implemented using a mn 2+ buffering system to avoid identifying unwanted inhibitors that act by sequestering mn 2+ in nonenzyme-bound metal chelates.
MAterIALS And MetHodS

Materials
PP i ase was obtained from roche applied Science (indianapolis, iN) as a suspension in ammonium sulfate solution. l-methionine was from Sigma (St. louis, mo). met-Glymet-met (mGmm) peptide was from Bachem (torrance, Ca). atP (Sigma) was dissolved in water and neutralized with Naoh. 5-(2-Chlorophenyl)-2-furohydrazide was purchased from Princeton Biomolecular research (monmouth Junction, NJ). 1,3-Diamino-2-hydroxypropane-N,N,N′,N′-tetraacetic acid (DahPta) was from aldrich (milwaukee, Wi). DahPta has also been referred to as hPDta. N-acetyl-l-tryptophanamide and n-octyl-β-D-glucopyranoside were from Sigma. other detergents were obtained from Pierce (rockford, il) as 10% solutions stored under inert gas and were kept frozen once the ampules were opened. eDta and ethylene glycol-bis (2-aminoethylether)-N,N,N′,N′-tetraacetic acid (eGta) were from Boston BioProducts (ashland, ma).
Malachite Green/molybdate P i detection
the reagent was prepared essentially as described by itaya and Ui. 24 for 1 l of reagent, 337 mg of malachite Green-hCl (Jt Baker, Phillipsburg, NJ) was dissolved in 750 ml of distilled water and stirred for 30 min. ammonium molybdate·4h 2 o (Sigma) (10.5 g) was dissolved in 250 ml of 4N hCl. the two solutions were mixed together gradually and then passed through a 0.2-µm filter. the reagent was stored at ambient temperature in darkness and was stable for several months. after addition of 1 to 1.5 volumes of malachite Green/molybdate reagent to enzyme reactions, 650-nm absorbance was measured following a 5-min incubation using a Spectramax plate reader (molecular Devices, Downington, Pa). reactions were performed in transparent polystyrene 384-well assay plates with no surface treatment (matrix technologies, hudson, Nh).
all enzyme assays were performed at ambient temperature (approximately 21°C).
Preparation of Escherichia coli MetK
Genomic DNa was isolated from Escherichia coli K-12 mG1655 25 using the Wizard Genomic DNa Purification Kit according to the manufacturer's protocol (Promega, madison, Wi). the E. coli gene metK (Sam synthetase) was amplified by PCr from mG1655 genomic DNa using high fidelity PCr master (roche applied Science) with the following primers purchased from eurofins mWG operon (huntsville, al): eCmetKliCf 5′-GaCGaCGaCaaGatGGCaaaaCaC CtttttaCGtCC-3′ and eCmetKliCr 5′-GaGGaGaa GCCCGG tttaCttCaGaCCGGCaGCat-3′.
the PCr product was purified using the QuickStep 2 PCr Purification Kit (edgeBio, Gaithersburg, mD) and then annealed to the expression vector pet-46 ek/liC according to the manufacturer's instructions (emD Chemicals, San Diego, Ca). transformants were checked for the presence of recombinant plasmids by colony PCr using the eCmetKliCf and t7 terminator (5′-GCtaGttattGCtCaGCGG-3′, purchased from eurofins mWG operon) primers. Plasmid DNa was isolated from PCr-positive transformants using the PureYield Plasmid miniprep System according to the manufacturer's protocol (Promega). the DNa sequence of the cloned metK gene was confirmed by sequencing on an aBi PriSm 3100 DNa sequencer (applied Biosystems, foster City, Ca) using the Big Dye terminator Cycle Sequencing Kit (applied Biosystems). Computer analysis of DNa sequences was performed with Sequencher (Gene Codes Corp., ann arbor, mi). the pet-46 ek/liC plasmid with cloned E. coli metK gene was designated pJt556 and allows for the highlevel expression of N-terminally his-tagged metK.
E. coli metK plasmid pJt556 was transformed into the E. coli Bl21(De3) plysS expression strain. Starter cultures were grown overnight in lB medium supplemented with 100 µg/ml ampicillin at 37°C. the overnight cultures were used to inoculate 4-l flasks containing 1 l of lB supplemented with 100 µg/ml ampicillin to a starting oD 600 of 0.1. the cells were grown at 23°C until oD 600 = 0.7 and then induced with 0.5 mm of isopropyl-β-D-thiogalactopyranoside (iPtG) at 23°C overnight until a final oD 600 of 6.5. Cells were harvested by centrifugation at 4°C for 15 min at 10 500 g. Pellets were stored at −20°C.
the frozen cell paste from 3 l of cell culture was resuspended in 50 ml of lysis buffer (25 . the dialyzed sample was applied at a flow rate of 2 ml/min onto a 20-ml Q-Sepharose hP (hr16/10) column (Ge healthcare life Sciences) preequilibrated with buffer B. after the column was washed with 100 ml of buffer B, the protein was eluted by a linear gradient from 0 to 1 m NaCl in buffer B. the fractions containing metK were pooled. Solid (Nh 4 ) 2 So 4 (0.4 g/ ml) was added to precipitate all the proteins and mixed on ice for 1 h. the sample was centrifuged at 130 000 g for 30 min at 4°C, and the pellet was then dissolved in 10 ml of buffer B. the 10-ml sample was applied at a flow rate of 1.5 ml/min to a 320-ml 
Preparation of E. coli MAP
the E. coli methionine aminopeptidase (map) gene was amplified by PCr from E. coli K-12 mG1655 genomic DNa using high fidelity PCr master (roche applied Science) with the following primers purchased from eurofins mWG operon: eCmaPf 5′-GatCtGCatatGGCtatCtCaatCaaGaCC CC-3′ and eCmaPr 5′-CttGatGtCGaCttattCGtCGt GCGaGatta-3′.
the PCr product was purified using the QuickStep 2 PCr Purification Kit (edgeBio), digested with Nde i and Sal i restriction enzymes (roche applied Science), and repurified using a QuickStep 2 cartridge. pet-30a plasmid (emD Chemicals) DNa was linearized by treatment with Nde i and Sal i, purified using a QuickStep 2 cartridge, dephosphorylated using calf intestine alkaline phosphatase (roche applied Science), electrophoresed on a 1% (w/v) agarose gel (Cambrex Bio Science rockland, rockland, me), and purified using the Zymoclean Gel DNa recovery Kit (Zymo research Co., orange, Ca) according to the manufacturer's instructions. the E. coli map fragment was ligated to pet-30a using the rapid DNa ligation Kit (roche applied Science) in accordance with the manufacturer's protocol. the ligation mixture was transformed into competent E. coli Dh5α (invitrogen, Carlsbad, Ca). transformants were analyzed for the presence of recombinant plasmids by colony PCr using high fidelity PCr master (roche applied Science) with eCmaPf and t7 terminator primers. Plasmid DNa isolation from PCr-positive transformants and DNa sequencing was performed as described above. the pet-30a plasmid with the cloned E. coli map gene was designated pJt7116.
E. coli maP plasmid pJt7116 was transformed into the E. coli Bl21(De3) expression strain. Starter cultures were grown overnight in lB medium supplemented with 30 µg/ml kanamycin at 37°C. the overnight cultures were used to inoculate 1 l of lB medium supplemented with 30 µg/ml final concentration of kanamycin in 4-l flasks with starting oD 600 = 0.1. the cells were grown at 30°C until oD 600 = 0.6, induced with 0.5 mm iPtG, and grown for an additional 3 h at 30°C, reaching oD 600 = 2.8. the cells were harvested by centrifugation at 4°C for 15 min at 10 500 g. the pellets were stored at −20°C.
the frozen cell paste was suspended in 60 ml of buffer D (20 mm tris-hCl [ph 7.5], 1 mm eDta, 1 mm dithiothreitol, 5% [v/v] glycerol, and one protease inhibitor cocktail tablet [roche molecular Biochemical]). Cells were disrupted by passing them twice through a french Press at 18 000 psi. the crude extract was centrifuged at 156 000 g for 30 min at 4°C. the supernatant was loaded at a flow rate of 2 ml/min onto a 20-ml Q-Sepharose hP (hr16/10) column (Ge healthcare life Sciences) preequilibrated with buffer D. the column was washed with buffer D, and the protein was eluted by a linear gradient from 0 to 1 m NaCl in buffer D. fractions containing maP were pooled, and solid (Nh 4 ) 2 So 4 was added to a final concentration of 1 m. the sample was applied at a flow rate of 2 ml/min to a 20-ml Phenyl Sepharose hP (hr16/10) column (Ge healthcare life Sciences) preequilibrated with buffer e (20 mm tris-hCl [ph 7.5], 1 mm eDta, 1 mm dithiothreitol, 5% [v/v] glycerol, 1m (Nh 4 ) 2 So 4 ). the column was washed with buffer e, and the protein was eluted by a linear gradient from 1 to 0 m (Nh 4 ) 2 So 4 in buffer D. fractions containing maP were pooled. Solid (Nh 4 ) 2 So 4 (0.4 g/ml) was added to precipitate all the proteins and mixed on ice for 1 h. the sample was centrifuged at 130 000 g for 30 min at 4°C (45ti rotor; Beckman-Coulter, Brea, Ca), and the pellet was then dissolved in 10 ml of buffer a. the 10-ml sample was applied at a flow rate of 1.5 ml/min to a 320-ml Sephacryl S-200 (hr 26/60) (Ge healthcare life Sciences) preequilibrated with buffer consisting of 20 mm tris-hCl (ph 7.5), 1 mm eDta, 1 mm dithiothreitol, 10% glycerol, and 150 mm NaCl. the fractions containing maP based on Uv absorbance and SDS-PaGe and having low-background (i.e., mGmm-independent) atPase activity were pooled. the protein was characterized by SDSPaGe analysis and analytical liquid chromatography/mass spectrometry (lC/mS). the protein was stored at −80°C.
Kinetic analysis
absorbance values from the metK/PP i ase-coupled maP assay with malachite Green/molybdate detection were converted into P i concentrations using a P i standard curve prepared in the assay buffer. the reaction rates (v) at a series of concentrations of mn 2+ (a) and mGmm (B) were fit to the rapid equilibrium random bisubstrate kinetic rate equation (see below) using nonlinear least squares regression with the program Grafit (erithacus Software, horley, Surrey, UK) to obtain the kinetic constants v max , K a , K b , and α.
Z′ measurement
the Z′ was measured for the metK/PP i ase-coupled maP assay using half of a 384-well assay plate for the minimum (miN) signal and half for the maximum (maX) signal. for the miN signal, the wells contained 6 mm eDta. for the maX signal, the wells contained 0.1% (v/v) DmSo. all wells contained 0.5 mm mGmm, 10 mm DahPta, 4.4 mm mnCl 2 , 0.3 mm atP, 8 nm E. coli maP, 400 nm metK, and 0.05 U/ml PP i ase in buffer consisting of 50 mm hePeS-Naoh (ph 7.5), 150 mm potassium acetate, 10% (v/v) glycerol, 4 mm mgCl 2 , 2 mm dithiothreitol, and 0.005% tween-20 detergent. then, 5 µl of 6× eDta and DmSo solutions was added by hand, and 10 µl of 2× mGmm/mnCl 2 /atP and 15 µl of 3× maP/metK/ PP i ase solutions were added using a Wellmate dispenser (matrix technologies). the reactions were quenched after 30 min with 30 µl of malachite Green/molybdate reagent. Z′ was calculated according to Zhang et al. 26 
Mn
2+ buffer selection
DahPta was selected as a buffering agent to provide free mn 2+ concentrations in the low micromolar range based on the published proton dissociation constants and mn 2+ stability constants 27 as well as mg 2+ stability constant. 28 this ligand has two relevant protonations for an assay in the ph 7-9 assay range with pK 3 = 6.96, pK 4 = 9.49, log K mn = 9.06, and log K mg = 5.3. the ph-adjusted apparent affinity of DahPta for mn 2+ and mg 2+ is described by the following equations, including correction for mixed ph and stability constants. 
in the presence of excess mg 2+ over DahPta, the apparent affinity for mn 2+ is further decreased by a factor of approximately [1 + [mg 2+ ] free /K D (mg)]. 30 thus, at ph 7.5, the predicted metal-binding affinities of the buffering system are K D (mn) = 150 nm, K D (mg) = 870 µm. in the case where an excess of mg 2+ is present over the chelator to yield ~5 mm free mg 2+ , the apparent mg-and ph-adjusted K D of DahPta for mn 2+ is ~1 µm. this calculation was made using the published stability constants determined at ionic strength 0.1 with KNo 3 at 25°C.at the higher ionic strength used in our assay, it is likely that the true K D (mn) is slightly higher but still appropriate for the desired purpose. reSuLtS the reaction scheme for the maP assay is shown below, with the enzyme catalyzing each step shown in parentheses.
1. met-Gly-met-met ↔ met + Gly-met-met (maP) 2. met + atP ↔ Sam + PP i + P i (metK) 3. PP i ↔ 2 P i (PP i ase)
it was desired that all three steps occur simultaneously, requiring that the rates of the coupling enzyme activities in the second and third steps be faster than the rate of maP in the first step so that only changes in the activity of maP would be detected. to keep the amount of metK protein required to a minimum, assay buffer conditions providing the maximal metK activity were determined. this was done by measuring the P i produced in 10 min over a range of met concentrations in the absence of maP. Because the maP reaction was to run for 30 min, complete conversion of the full range of met concentrations in 10 min would allow for at least a threefold excess of metK coupler activity over that required to convert all of the met product of the maP reaction to Sam. Figure 1A shows met standard curves obtained in a 10-min reaction with various concentrations of metK and atP, after subtraction of the no-metK background, in the presence of excess PP i ase activity (see Supplemental Figure S1 ). the large absorbance changes were directly proportional to the met concentration in the range 0 to 5.5 µm met. the increase in slope of the standard curve with increasing metK and atP concentrations shows that the conversion of met to Sam by metK was not quite complete in 10 min with the lower metK and atP concentrations.
Similar experiments with a rate-limiting metK concentration were used to identify the best buffer salt and ph conditions for the metK reaction near neutral ph (Fig. 1B) . although the differences were small, the steepest slope of the met standard curve, representing the fastest rate of metK catalysis, was obtained with hePeS-Naoh (ph 7.5 or 8.0). the effects of several salts of monovalent cations on metK activity were measured over a range of concentrations (Fig.  1c) . metK was activated by potassium and ammonium ions but not sodium ions. this result is consistent with published observations. , and Co 2+ (Fig. 1d) ) with 75 nm metK, 0.6 mm atP, and 0.1 U/ml PP i ase. the met concentration ranged from 0 to 5.5 µm. the average of two measurements at each concentration was used to calculate the slope of the standard curve, representing the rate of the 10-min metK reaction. the 30-µl reactions were quenched with 45 µl of malachite Green/molybdate reagent. the baseline absorbances were 0.13 to 0.14. (c) effect of salt type and concentration on the rate of the metK reaction. the buffers contained 50 mm hePeS-Naoh (ph 7.5), 10 mm mgCl 2 , 2 mm dithiothreitol, 0.005% tween-20, and salt as indicated. the 30-µl reactions contained 5 µm met, 0.6 mm atP, 0.1 U/ml PP i ase, and 0 or 75 nm metK. the reactions were quenched after 10 min with 45 µl of malachite Green/molybdate reagent. the background for reactions without metK, which varied depending on the identity and concentration of the salt, was subtracted. (d) effect of divalent metal cations on the rate of the metK reaction. the buffers contained 50 mm hePeS-Naoh (ph 7.5), 150 mm potassium acetate, 0.005% tween-20, and salt as indicated. the 30-µl reactions contained 5 µm met, 0.6 mm atP, 0.1 U/ml PP i ase, and 0 or 75 nm metK. the reactions were quenched after 10 min with 45 ml of malachite Green/molybdate reagent. the background for reactions without metK was subtracted. the baseline absorbance was 0.15 for mgCl 2 . 23 the divalent metal activation of metK shown in Figure 1d may have been, at least at the lowest metal ion concentrations, a composite of the activation of metK and PP i ase. Because of the relatively high activity of PP i ase, however (see Supplemental Figure S1 ), it is likely that metK was rate limiting.
Based on the above observations, the buffer conditions selected for use with metK consisted of 50 mm hePeS-Naoh (ph 7.5), 150 mm potassium acetate, and 4 to 10 mm mgCl 2 .
Nonionic detergents at submicellar concentrations are often added to microplate-based assays to help reduce loss of enzyme activity due to adsorption of proteins to the polystyrene surface. We tested Brij-35, tween-20, triton X-100, and n-octyl-β-D-glucopyranoside (noG) for this purpose by measuring met standard curves over a range of detergent concentrations. all the detergents performed satisfactorily at concentrations well below their critical micellar concentrations: as low as 0.002% for Brij-35, tween-20, and triton X-100 or 4 mm for noG (data not shown). Brij-35 or triton X-100 at 0.005% was used subsequently.
maP is activated by transition metal cations, such as mn , but it has not been reported to be activated by mg 2+ . By using mg 2+ in the buffer to activate metK, it is possible to use the metK/PP i ase coupler for a maP assay in which the level of maP activation by other cations can be controlled, as long as they do not substantially inhibit the metK/ PP i ase couple. the effect of several divalent transition metal cations on metK/PP i ase activity in the presence of 10 mm mgCl 2 is shown in Figure 2A . in this experiment, the metK concentration was set low enough and the mgCl 2 concentration was set high enough to reveal the inhibitory effects of the cations. mn did not cause inhibition in this range but was substantially inhibitory in the 2-to 20-mm range (Fig. 2B) . at mgCl 2 concentrations lower than 5 mm, which are insufficient to fully activate metK, the addition of 0 to 160 µm mn 2+ was stimulatory rather than inhibitory, whereas at 5 mm mgCl 2 , there was no apparent effect of mnCl 2 (data not shown). for subsequent investigations, mn 2+ was used to activate maP because of its weak inhibition of the metK/PP i ase couple and its compatibility with the presence of dithiothreitol as a reductant and protective agent during screening. were to be used, it would be necessary to omit dithiothreitol, which forms a complex with and, in some cases, reduces the cation. maP binds with relatively low affinity to most oligopeptide substrates, so peptide concentrations in the millimolar range may be used. We tested the metK/PP i ase-coupled detection of met for interference by the maP substrate mGmm. 31, 32 No effect on either the background or the activity was found with mGmm concentrations up to 3 mm (data not shown). this commercially available peptide was used as the maP substrate for subsequent investigations.
essentially, linear reaction progress curves were obtained with E. coli maP using the metK/PP i ase-coupled assay and the malachite Green/molybdate reagent for detection (Fig. 3) . the amount of P i production after 30 min was directly proportional to the maP concentration (Supplemental Figure S2) . the direct proportionality between maP concentration and product formation demonstrates the sufficiency of the activity of the metK/PP i ase coupler (i.e., for maP concentrations up to 15 nm, it was the maP that was rate limiting). the metK/PP i ase-coupled assay was used to measure kinetic constants for mn 2+ -activated E. coli maP by varying the concentrations of mGmm and mn 2+ (Fig. 4) . the data were fit to the rapid equilibrium random bisubstrate rate equation. the activating mn 2+ was treated as a substrate for the purpose of the analysis, although it is not consumed in the reaction. 33 this allowed the activation constant K a (mn 2+ ) to be determined to be 3.0 µm. K d (mGmm) was 1.0 mm. the α factor was 1.2, which shows that there was little binding interaction between mn 2+ and mGmm. the K m for mn 2+ , which is equal to αK a , was 4 µm. the K m for mGmm, which is equal to αK b , was 1.2 mm, similar to the K m of 1.3 mm in the presence of mn 2+ reported by Watterson et al. 34 the justification for choosing the rapid equilibrium random bisubstrate rate equation to fit the E. coli maP kinetic data was the pair of observations that E. coli maP was capable of binding to peptide substrate in the absence of activating divalent metal cations and also that it was capable of binding to activating divalent metal cations in the absence of peptide substrate. these observations were made using the effects of mGmm and mn 2+ on the intrinsic tryptophan fluorescence of E. coli maP (Supplemental Figure S3) . the 342-nm tryptophan fluorescence emission increased with the ligand concentration in both cases.there was no significant effect of mGmm titration on the negative control N-acetyl-l-tryptophanamide (Nata) fluorescence, except for an increase at 6.4 mm (Supplemental Figure S3A) , whereas the maP fluorescence increased over the range of mGmm concentrations tested. the difference in relative fluorescence between the maP and Nata titrations with mGmm as a function of mGmm concentration could be fit to a binding isotherm to obtain a K d for mGmm of approximately 1.5 mm (not shown), consistent with the K d of 1.0 mm measured in the kinetic experiment (Fig. 4) . in the titration of maP with mnCl 2 (Supplemental Figure S3B) , there was no significant effect of mnCl 2 titration on Nata fluorescence, except for a slight increase at 64 µm, but a large stepwise fluorescence increase was observed once the mnCl 2 concentration exceeded the residual concentration of eDta carried over from FIg. 3 . reaction progress curves for Escherichia coli methionine aminopeptidase (maP) in the metK/PP i ase-coupled assay. the 30-µl reactions contained 50 mm hePeS-Naoh (ph 7.5), 150 mm potassium acetate, 10% (v/v) glycerol, 4 mm mgCl 2 , 2 mm dithiothreitol, 0.005% Brij-35 detergent, 4 µm mnCl 2 , 1 mm met-Gly-met-met (mGmm), 400 nm metK, 1 U/ml PP i ase, 0.3 mm adenosine triphosphate (atP), and E. coli maP as shown. the reactions were quenched with 30 µl of malachite Green/molybdate reagent. absorbance readings were converted to P i concentrations using a P i standard curve prepared in the assay buffer. the background from reactions without maP was subtracted. the baseline P i concentration increased from 1.2 µm at 3 min to 3 µm at 57 min. each data point represents the difference between single measurements.
FIg. 4. measurement of kinetic constants for
Escherichia coli methionine aminopeptidase (maP) in the metK/PP i ase-coupled assay. the 30-µl reactions contained 50 mm hePeS-Naoh (ph 7.5), 150 mm potassium acetate, 10% (v/v) glycerol, 4 mm mgCl 2 , 2 mm dithiothreitol, 0.005% Brij-35 detergent, 400 nm metK, 1 U/ml PP i ase, 0.3 mm adenosine triphosphate (atP), 3.33 nm E. coli maP, and a range of mnCl 2 and met-Gly-met-met (mGmm) concentrations as shown. the reactions were quenched after 1 h with 30 µl of malachite Green/molybdate reagent. averages of three replicate absorbance readings were converted to P i concentrations using a P i standard curve prepared in the assay buffer. at each mn 2+ concentration, the background amount of P i produced in the absence of mGmm, 1.5-2.2 µm, was subtracted. the maximal concentration of P i produced in 60 min was 16.6 µm, well within the capacity of the metK/ PP i ase coupler, which is at least 28 µm P i /h (Supplemental Figure  S2) -that is, maP activity was rate limiting. the data were fit to the rapid equilibrium random bisubstrate rate equation (see materials and methods).
the maP protein storage buffer. mn 2+ binding to maP was saturated with 32 µm mn 2+ in the presence of 13 µm eDta, indicating a K d for mn 2+ binding to maP well below 19 µm. this result is consistent with the observed 3 µm K d obtained from the kinetic experiment (Fig. 4) .
the kinetic constants for E. coli maP were used to set up an assay to measure inhibitor potency that would have similar sensitivities for inhibitors competitive with the peptide substrate, whether or not mn 2+ were bound to the enzyme, by fixing the concentration of free mn 2+ approximately equal to its activation constant. the assay contained 0.5 mm mGmm and 4 µm mnCl 2 . the result for a previously reported inhibitor of E. coli maP activated by mn . huang et al. 35 reported an iC 50 of 6.6 µm at 100 µm mn
2+
. these results confirm that the metK/PP i ase-coupled maP assay responds as expected to maP inhibition.
Because test compounds in screening libraries are typically dissolved in DmSo, this solvent is introduced into the assay. We therefore tested the metK/PP i ase-coupled maP assay for the effect of DmSo (Supplemental Figure S4) . DmSo was inhibitory toward E. coli maP in a range of concentrations likely to be encountered when screening compounds for inhibitory properties. this inhibition was not due to interference with the metK/PP i ase coupler or the malachite Green/molybdate reagent because there was no effect of DmSo in the same range of concentrations on met standard curves generated under the same conditions, with met substituted for maP and mGmm (data not shown). Because of the effect of DmSo on maP activity, it is necessary to maintain DmSo at a constant concentration for all samples and controls when using the assay for screening compound libraries or measuring inhibitor potencies.
Because of the low concentration of mn 2+ used in the assay described above, test compounds containing mn 2+ -chelating moieties could inhibit maP by depleting the buffer of mn 2+ instead of, or in addition to, binding to the active site. regardless of the divalent metal cation used to activate maP, this problem could be avoided either by raising the metal ion concentration or, if a low concentration is desired, by buffering the metal ion concentration. We illustrate the latter approach by buffering the mn 2+ concentration with DahPta, which has a much greaterintrinsic affinity of the fully deprotonated ligand for mn 2+ (K d ~1 nm 27 ) than for mg 2+ (K d ~5 µm 28 ) and can therefore be used to buffer the mn 2+ concentration in the presence of mg 2+ used to activate metK and PP i ase. in the presence of 1 mm DahPta and 4 mm mgCl 2 , activation of maP by mnCl 2 required an approximately 100-fold higher total concentration than when DahPta was absent (Supplemental Figure S5A) because of the buffering of mn 2+ by DahPta, and the maP activity was directly proportional to the mn 2+ concentration. Supplemental Figure S5B shows that 4 mm mgCl 2 was still sufficient for full activity of the metK/PP i ase couple in the presence of 3.3 mm DahPta and 1.5 mm mnCl 2 . the mn 2+ concentration needed -activated Escherichia coli methionine aminopeptidase (maP) by 5-(2-chlorophenyl)-2-furohydrazide (inset). the compound was dissolved at 10 mm in DmSo. twofold serial dilutions were prepared using DmSo as the diluent, and 0.6 µl of the compound dilutions was transferred to the wells of an assay plate. assay reagents were added to a final volume of 30 µl containing 0.3 mm adenosine triphosphate (atP), 0.5 mm met-Gly-met-met (mGmm), 400 nm metK, 0.05 U/ml PP i ase, and 5 to 10 nm E. coli maP with 4, 20, or 100 µm mnCl 2 in buffer consisting of 50 mm hePeS-Naoh (ph 7.5), 150 mm potassium acetate, 10% (v/v) glycerol, 4 mm mgCl 2 , 2 mm dithiothreitol, and 0.005% Brij-35 detergent. in a second set of duplicate wells, the maP was omitted. the reactions were quenched after 30 min with 45 µl of malachite Green/molybdate reagent, and the average of triplicate absorbance measurements was calculated. the percent inhibition at each inhibitor concentration was calculated using the absorbance without maP at each concentration as a baseline. the baseline absorbance in the absence of the inhibitor was 0.15 to 0.17 and was not significantly affected by the compound. the absorbance measurement for the uninhibited reaction was 0.24 to 0.28. the percent inhibition data were fit to the three-parameter hill equation: to achieve a given level of maP activity increased in approximately direct proportion to the DahPta concentration up to at least 10 mm DahPta and 4.4 mm mn 2+ , consistent with the metal buffering system fixing the free mn 2+ concentration at a constant total mn 2+ to total DahPta ratio as expected (data not shown). Under these conditions, even tight chelation of mn 2+ by test compounds, which are commonly present at ≤100 µm, would have no significant effect on the availability of mn 2+ for activation of maP. for compound activity screening with 10 µm compound present, 1 mm DahPta and 400 µm mnCl 2 would be sufficient to avoid detecting potent mn 2+ chelators as maP inhibitors. Figure 6 shows that 10 mm DahPta + 4.4 mm mnCl 2 reduced the sensitivity of E. coli maP to inhibition by the mn 2+ chelators eDta and eGta by more than 500-fold compared with unbuffered 4 µm mnCl 2 .
titration of the PP i ase concentration shows that only about 0.01 U/ml was required for maximal signal generation in the metK/PP i ase-coupled maP assay buffered with DahPta (Supplemental Figure S1) . thus, the amount typically used, 0.05 to 0.1 U/ml, was sufficient to ensure that conversion of PP i to P i was not rate limiting.
the Z′ statistic is an often-used figure of merit for htS assays that relates the signal to the background and noise. 26 a value of 0.5 is considered the minimal acceptable value for a satisfactory screen, with 1 being the maximal possible value. Z′ was measured for the metK/PP i ase-coupled maP assay, as described in materials and methods. the average absorbance difference between maX and miN was 0.185, and the Z′ was 0.83, demonstrating satisfactory performance for htS.
htS assays typically require several hours of continuous screening in a single day. it is important, therefore, that the reagents retain stability over this period. the stability of the metK/PP i ase-coupled assay of E. coli maP was investigated using the reagents described in the Z′ section of materials and methods. the reagents were stored in polypropylene containers at ambient temperature for 9 h. except for a slight reduction in the maX signal between 0 and 2 h, the assay produced a consistent signal for 9 h (data not shown). dIScuSSIon the metK/PP i ase-coupled maP assay described here provides a robust, sensitive, high-throughput method for the measurement of maP enzyme activity. the assay is useful for screening collections of compounds and extracts for inhibitors of maP, measuring the potency of inhibitors, and conducting investigations of the kinetic mechanisms of maP and its inhibitors. Because the assay measures the release of met from the N-terminus of peptides, it can be used with any maP substrate; no specialized, nonphysiological, nonpeptide analogues of maP are required, as in some other published maP assays. Natural peptides have the advantages that they are readily obtained commercially with any desired sequence and do not pose the risk of finding inhibitors that are specific to an unnatural peptide analog. the amplification of 3 P i /met allows for the accurate quantitation by absorbance of as little as 1 µm met, using the malachite Green/molybdate reagent for P i detection. Given the ~10 3 µm K m of E. coli maP for short peptide substrates, this level of sensitivity is sufficient for a screening assay with as little as ~30 µm peptide. the malachite Green/ molybdate reagent is simple and inexpensive to prepare and stable for months at ambient temperature. the PP i ase required for the assay can be obtained commercially at low cost. the his-tagged E. coli metK enzyme that is the basis for the coupled assay is readily produced in large amounts by overexpression of the metK gene in E. coli and purification by standard methods of chromatography. to avoid high P i background in the assay, care should be taken during purification to minimize contaminating atP hydrolyzing enzymes in the maP and metK preparations.
the metK concentration needed for continuous conversion of met produced by the maP reaction to Sam could be reduced, if Buffer 2 contained 4.4 mm mnCl 2 and 10 mm DahPta-Naoh (ph 7.5). twofold serial dilutions of 10 mm eDta-Naoh (ph 8.0) and 10 mm eGta-Naoh (ph 8.0) were prepared in each buffer, and 3 µl was added to the wells of an assay plate. reagents were added to a final volume of 30 µl containing 0.3 mm adenosine triphosphate (atP), 0.5 mm met-Gly-met-met (mGmm), 400 nm metK, 0.05 U/ml PP i ase, and 10 nm E. coli maP. the reactions were quenched after 30 min with 45 µl of malachite Green/molybdate reagent, and the average of triplicate absorbance measurements was calculated. the percent inhibition at each inhibitor concentration was calculated using the absorbance without maP at each concentration as a baseline. the baseline absorbance in the absence of inhibitor was 0.15 and was not significantly affected by the inhibitor or buffer. the absorbance measurement for the uninhibited reaction was 0.56 in buffer 1 and 0.35 in buffer 2.
